The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.

Cancers (Basel) · 2023 · PMC10571776 · PMID 37835569

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

This difference was apparent as early as six weeks after treatment initiation, indicating that the composition of the gut microbiota could potentially serve as an early predictor of treatment outcome [ 35 ].

also in 205 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.